Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Relmada Therapeutics (RLMD) Equity Average (2016 - 2026)

Relmada Therapeutics has reported Equity Average over the past 2 years, most recently at -$29593.0 for Q1 2014.

  • Quarterly Equity Average changed N/A to -$29593.0 in Q1 2014 from the year-ago period, while the trailing twelve-month figure was -$29593.0 through Feb 2014, changed N/A year-over-year, with the annual reading at -$1149.5 for FY2013, N/A changed from the prior year.
  • Equity Average was -$29593.0 for Q1 2014 at Relmada Therapeutics, down from -$20844.0 in the prior quarter.
  • Over five years, Equity Average peaked at -$11550.5 in Q2 2013 and troughed at -$29593.0 in Q1 2014.